Multifunctional systems based on nano-in-microparticles as strategies for drug delivery: advances, challenges, and future perspectives

References

• Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26:5905. doi: 10.3390/molecules26195905
   PubMed Web of Science ®Google Scholar
• Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. Int J Pharm. 2010;395:44–52. doi: 10.1016/j.ijpharm.2010.05.003
   PubMed Web of Science ®Google Scholar
• Hu Q, Chen Q, Gu Z. Advances in transformable drug delivery systems. Biomaterials. 2018;178:546–558. doi: 10.1016/j.biomaterials.2018.03.056
   PubMed Web of Science ®Google Scholar
• Qin S-Y, Zhang A-Q, Cheng S-X, et al. Drug self-delivery systems for cancer therapy. Biomaterials. 2017;112:234–247. doi: 10.1016/j.biomaterials.2016.10.016
   PubMed Web of Science ®Google Scholar
• Nel AE, Mädler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano–bio interface. Nat Mater. 2009;8:543–557. doi: 10.1038/nmat2442
   PubMed Web of Science ®Google Scholar
• Pelaz B, Alexiou C, Alvarez-Puebla RA, et al. Diverse applications of nanomedicine. ACS Nano. 2017;11:2313–2381. doi: 10.1021/acsnano.6b06040
   PubMed Web of Science ®Google Scholar
• dos Santos AM, Carvalho SG, Meneguin AB, et al. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: challenges, advances and future perspectives. J Controlled Release. 2021;334:353–366. doi: 10.1016/j.jconrel.2021.04.026
   PubMed Web of Science ®Google Scholar
• Yang J, Zhao Y, Zhou Y, et al. Advanced nanomedicines for the regulation of cancer metabolism. Biomaterials. 2022;286:121565. doi: 10.1016/j.biomaterials.2022.121565
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Kumar A, et al. PH-Sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014;32:693–710. doi: 10.1016/j.biotechadv.2013.11.009
   PubMed Web of Science ®Google Scholar
• Anton N, Jakhmola A, Vandamme TF. Trojan microparticles for drug delivery. Pharmaceutics. 2012;4:1–25. doi: 10.3390/pharmaceutics4010001
   PubMedGoogle Scholar
• Abdelaziz MM, Hefnawy A, Anter A, et al. Respirable spray dried vancomycin coated magnetic nanoparticles for localized lung delivery. Int J Pharm. 2022;611:121318. doi: 10.1016/j.ijpharm.2021.121318
   PubMedGoogle Scholar
• Spindler LM, Feuerhake A, Ladel S, et al. Nano-in-micro-particles consisting of PLGA nanoparticles embedded in chitosan microparticles via spray-drying enhances their uptake in the olfactory mucosa. Front Pharmacol. 2021;12:1–19. doi: 10.3389/fphar.2021.732954
   Web of Science ®Google Scholar
• Forest V, Pourchez J. Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient? Adv Drug Deliv Rev. 2022;183:114173.
   PubMed Web of Science ®Google Scholar
• Elbaz NM, Khalil IA, Abd-Rabou AA, et al. Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis. Int j biol macromol. 2016;92:254–269. doi: 10.1016/j.ijbiomac.2016.07.024
   PubMed Web of Science ®Google Scholar
• Li Q, Xue F, Qu J, et al. Nano-in-micro delivery system prepared by co-axial air flow for oral delivery of conjugated linoleic acid. Mar Drugs. 2019;17:15. doi: 10.3390/md17010015
   Web of Science ®Google Scholar
• Ramakrishna S, Mayer J, Wintermantel E, et al. Biomedical applications of polymer-composite materials: a review. Compos Sci Technol. 2001;61:1189–1224. doi: 10.1016/S0266-3538(00)00241-4
   Web of Science ®Google Scholar
• Zhang Y, Chan HF, Leong KW. Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev. 2013;65:104–120. doi: 10.1016/j.addr.2012.10.003
   PubMed Web of Science ®Google Scholar
• Kanamala M, Wilson WR, Yang M, et al. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review. Biomaterials. 2016;85:152–167. doi: 10.1016/j.biomaterials.2016.01.061
   PubMed Web of Science ®Google Scholar
• Li X, Yu M, Zhu Z, et al. Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease. Carbohydr Polym. 2021;273:118556. doi: 10.1016/j.carbpol.2021.118556
   PubMed Web of Science ®Google Scholar
• Soudry-Kochavi L, Naraykin N, Di Paola R, et al. Pharmacodynamical effects of orally administered exenatide nanoparticles embedded in gastro-resistant microparticles. Eur J Pharm Biopharm. 2018;133:214–223. doi: 10.1016/j.ejpb.2018.10.013
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu D, Shahbazi M-A, et al. Fabrication of a multifunctional nano-in-micro drug delivery platform by microfluidic templated encapsulation of porous silicon in polymer matrix. Adv Mater. 2014;26:4497–4503. doi: 10.1002/adma.201400953
   PubMed Web of Science ®Google Scholar
• dos Santos AM, Meneguin AB, Akhter DT, et al. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract. Eur J Pharm Biopharm. 2021;158:371–378. doi: 10.1016/j.ejpb.2020.12.004
   PubMed Web of Science ®Google Scholar
• Abdelrady H, Hathout RM, Osman R, et al. Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy. Eur J Pharmaceut Sci. 2019;133:115–126. doi: 10.1016/j.ejps.2019.03.016
   PubMed Web of Science ®Google Scholar
• Price DN, Stromberg LR, Kunda NK, et al. In vivo pulmonary delivery and magnetic-targeting of dry powder nano-in-microparticles. Mol Pharm. 2017;14:4741–4750. doi: 10.1021/acs.molpharmaceut.7b00532
   PubMed Web of Science ®Google Scholar
• Zheng Z, Pan X, Luo L, et al. Advances in oral absorption of polysaccharides: mechanism, affecting factors, and improvement strategies. Carbohydr Polym. 2022;282. doi: 10.1016/j.carbpol.2022.119110
   Web of Science ®Google Scholar
• Yuan H, Guo C, Liu L, et al. Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides. Carbohydr Polym. 2023;312:120838. doi: 10.1016/j.carbpol.2023.120838
   PubMed Web of Science ®Google Scholar
• Ferreira LMB, dos Santosdos Santos AM, Boni FI, et al. Design of chitosan-based particle systems: a review of the physicochemical foundations for tailored properties. Carbohydr Polym. 2020;250:116968. doi: 10.1016/j.carbpol.2020.116968
   PubMed Web of Science ®Google Scholar
• Carvalho SG, dos Santos AM, Silvestre ALP, et al. New insights into physicochemical aspects involved in the formation of polyelectrolyte complexes based on chitosan and dextran sulfate. Carbohydr Polym. 2021;271:118436.
   PubMed Web of Science ®Google Scholar
• Akhter DT, Simpson JD, Fletcher NL, et al. Oral delivery of multicompartment nanomedicines for colorectal cancer therapeutics: combining loco‐regional delivery with cell‐target specificity. Adv Ther. 2020;3:1900171. doi: 10.1002/adtp.201900171
   Google Scholar
• Musa N, Wong TW. Design of polysaccharidic nano-in-micro soft agglomerates as primary oral drug delivery vehicle for colon-specific targeting. Carbohydr Polym. 2020;247. doi: 10.1016/j.carbpol.2020.116673
   PubMed Web of Science ®Google Scholar
• Du J, El-Sherbiny IM, Smyth HD. Swellable ciprofloxacin-loaded nano-in-micro hydrogel particles for local lung drug delivery. AAPS Pharm Sci Tech. 2014;15:1535–1544. doi: 10.1208/s12249-014-0176-x
   PubMed Web of Science ®Google Scholar
• Pawar SN, Edgar KJ. Alginate derivatization: a review of chemistry, properties and applications. Biomaterials. 2012;33:3279–3305. doi: 10.1016/j.biomaterials.2012.01.007
   PubMed Web of Science ®Google Scholar
• Santos C, de Araújo Gonçalves M, de Macedo LF, et al. Green nanotechnology for the development of nanoparticles based on alginate associated with essential and vegetable oils for application in fruits and seeds protection. Int j biol macromol. 2023;232:123351. doi: 10.1016/j.ijbiomac.2023.123351
   PubMed Web of Science ®Google Scholar
• Ma Y, Fuchs AV, Boase NRB, et al. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: evaluation of their potential for colon-specific delivery. Eur J Pharm Biopharm. 2015;94:393–403. doi: 10.1016/j.ejpb.2015.06.014
   PubMed Web of Science ®Google Scholar
• Restani RB, Pires RF, Tolmatcheva A, et al. Poxylated Dendrimer-based nano-in-micro dry powder formulations for inhalation chemotherapy. ChemistryOpen. 2018;7:772–779. doi: 10.1002/open.201800093
   PubMed Web of Science ®Google Scholar
• Silva AS, Sousa AM, Cabral RP, et al. Aerosolizable gold nano-in-micro dry powder formulations for theragnosis and lung delivery. Int J Pharm. 2017;519:240–249. doi: 10.1016/j.ijpharm.2017.01.032
   PubMedGoogle Scholar
• Ferreira LMB, Cardoso VMO, dos Santos Pedriz I, et al. Understanding mucus modulation behavior of chitosan oligomers and dextran sulfate combining light scattering and calorimetric observations. Carbohydr Polym. 2023;306:120613. doi: 10.1016/j.carbpol.2023.120613
   PubMed Web of Science ®Google Scholar
• Li W, Liu D, Zhang H, et al. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy. Acta Biomater. 2017;48:238–246. doi: 10.1016/j.actbio.2016.10.042
   PubMed Web of Science ®Google Scholar
• Li W, Li Y, Liu Z, et al. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine. Biomaterials. 2018;185:322–332. doi: 10.1016/j.biomaterials.2018.09.024
   PubMed Web of Science ®Google Scholar
• Costa C, Liu Z, Martins JP, et al. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery. Biomater Sci. 2020;8:3270–3277. doi: 10.1039/d0bm00743a
   PubMed Web of Science ®Google Scholar
• Liu L, Fishman ML, Kost J, et al. Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials. 2003;24:3333–3343. doi: 10.1016/S0142-9612(03)00213-8
   PubMed Web of Science ®Google Scholar
• Varki A, Cummings RD, Aebi M, et al. Symbol nomenclature for graphical representations of glycans. Glycobiology. 2015;25:1323–1324. doi: 10.1093/glycob/cwv091
   PubMed Web of Science ®Google Scholar
• Valente SA, Silva LM, Lopes GR, et al. Polysaccharide-based formulations as potential carriers for pulmonary delivery – a review of their properties and fates. Carbohydr Polym. 2022;277. doi: 10.1016/j.carbpol.2021.118784
   PubMed Web of Science ®Google Scholar
• de Oliveira Cardoso VM, Stringhetti Ferreira Cury B, Evangelista RC, et al. Development and characterization of cross-linked gellan gum and retrograded starch blend hydrogels for drug delivery applications. J Mech Behav Biomed Mater. 2017;65:317–333. doi: 10.1016/j.jmbbm.2016.08.005
   PubMed Web of Science ®Google Scholar
• Meneguin AB, Beyssac E, Garrait G, et al. Retrograded starch/pectin coated gellan gum-microparticles for oral administration of insulin: a technological platform for protection against enzymatic degradation and improvement of intestinal permeability. Eur J Pharm Biopharm. 2018;123:84–94. doi: 10.1016/j.ejpb.2017.11.012
   PubMed Web of Science ®Google Scholar
• He Y, Liang Y, Han R, et al. Rational particle design to overcome pulmonary barriers for obstructive lung diseases therapy. J Controlled Release. 2019;314:48–61. doi: 10.1016/j.jconrel.2019.10.035
   PubMed Web of Science ®Google Scholar
• Lee Y-S, Johnson PJ, Robbins PT, et al. Production of nanoparticles-in-microparticles by a double emulsion method: a comprehensive study. Eur J Pharm Biopharm. 2013;83:168–173. doi: 10.1016/j.ejpb.2012.10.016
   PubMed Web of Science ®Google Scholar
• Huck BC, Thiyagarajan D, Bali A, et al. Nano‐in‐microparticles for aerosol delivery of antibiotic‐loaded, fucose‐derivatized, and macrophage‐targeted liposomes to combat mycobacterial infections: In Vitro deposition, pulmonary barrier interactions, and targeted delivery. Adv Healthc Mater. 2022;11:2102117. doi: 10.1002/adhm.202102117
   Web of Science ®Google Scholar
• Soukoulis C, Bohn T. A comprehensive overview on the micro- and nano-technological encapsulation advances for enhancing the chemical stability and bioavailability of carotenoids. Crit Rev Food Sci Nutr. 2018;58:1–36. doi: 10.1080/10408398.2014.971353
   PubMed Web of Science ®Google Scholar
• Sharma A, Vaghasiya K, Gupta P, et al. Reclaiming hijacked phagosomes: hybrid nano-in-micro encapsulated MIAP peptide ensures host directed therapy by specifically augmenting phagosome-maturation and apoptosis in TB infected macrophage cells. Int J Pharm. 2018;536:50–62. doi: 10.1016/j.ijpharm.2017.11.046
   PubMedGoogle Scholar
• Cid-Samamed A, Rakmai J, Mejuto JC, et al. Cyclodextrins inclusion complex: preparation methods, analytical techniques and food industry applications. Food Chem. 2022;384:132467. doi: 10.1016/j.foodchem.2022.132467
   PubMed Web of Science ®Google Scholar
• Bamidele OP, Emmambux MN. Encapsulation of bioactive compounds by “extrusion” technologies: a review. Crit Rev Food Sci Nutr. 2021;61:3100–3118. doi: 10.1080/10408398.2020.1793724
   PubMed Web of Science ®Google Scholar
• Li Y, Xu M, Xia Y, et al. Multilayer assembly of electrospun/electrosprayed PVDF-based nanofibers and beads with enhanced piezoelectricity and high sensitivity. Chem Eng J. 2020;388:124205. doi: 10.1016/j.cej.2020.124205
   Web of Science ®Google Scholar
• Arshad MS, Mujeeb M, Zafar S, et al. EHDA engineering of piroxicam-PVP components for pharmaceutical dosages. J Drug Deliv Sci Technol. 2022;78:103927. doi: 10.1016/j.jddst.2022.103927
   Web of Science ®Google Scholar
• Zhang C, Li Y, Hu Y, et al. Porous yolk–shell particle engineering via nonsolvent-assisted trineedle coaxial electrospraying for burn-related wound healing. ACS Appl Mater Interfaces. 2019;11:7823–7835. doi: 10.1021/acsami.8b22112
   PubMed Web of Science ®Google Scholar
• Yao Z-C, Zhang C, Ahmad Z, et al. Microparticle formation via tri-needle coaxial electrospray at stable jetting modes. Ind Eng Chem Res. 2020;59:14423–14432. doi: 10.1021/acs.iecr.0c02677
   Web of Science ®Google Scholar
• Wang B, Liu F, Xiang J, et al. A critical review of spray-dried amorphous pharmaceuticals: synthesis, analysis and application. Int J Pharm. 2021;594:120165. doi: 10.1016/j.ijpharm.2020.120165
   PubMedGoogle Scholar
• Party P, Bartos C, Farkas Á, et al. Formulation and in vitro and in silico characterization of “nano-in-micro” dry powder inhalers containing meloxicam. Pharmaceutics. 2021;13:1–18. doi: 10.3390/pharmaceutics13020211
   Web of Science ®Google Scholar
• Arpagaus C, Collenberg A, Rütti D, et al. Nano spray drying for encapsulation of pharmaceuticals. Int J Pharm. 2018;546:194–214. doi: 10.1016/j.ijpharm.2018.05.037
   PubMed Web of Science ®Google Scholar
• Vishali DA, Monisha J, Sivakamasundari SK, et al. Spray freeze drying: emerging applications in drug delivery. JControlled Release. 2019;300:93–101. doi: 10.1016/j.jconrel.2019.02.044
   PubMed Web of Science ®Google Scholar
• Carvalho SG, Cipriano F, Checon JC, et al. 2020;10:1788–1809. doi: 10.1007/s13346-020-00841-1
   Google Scholar
• Richter Ł, Stevens CA, Silva PJ, et al. Peptide-grafted nontoxic cyclodextrins and nanoparticles against bacteriophage infections. ACS Nano. 2022;16:18990–19001. doi: 10.1021/acsnano.2c07896
   PubMed Web of Science ®Google Scholar
• Shelley H, Babu RJ. Role of cyclodextrins in nanoparticle-based drug delivery systems. J Pharm Sci. 2018;107:1741–1753. doi: 10.1016/j.xphs.2018.03.021
   PubMed Web of Science ®Google Scholar
• Banerjee SL, Das S, Bhattacharya K, et al. Ag NPs incorporated self-healable thermoresponsive hydrogel using precise structural “interlocking” complex of polyelectrolyte BCPs: a potential new wound healing material. Chem Eng J. 2021;405:126436. doi: 10.1016/j.cej.2020.126436
   Web of Science ®Google Scholar
• Pedroso-Santana S, Fleitas-Salazar N. Ionotropic gelation method in the synthesis of nanoparticles/microparticles for biomedical purposes. Polym Int. 2020;69:443–447. doi: 10.1002/pi.5970
   Web of Science ®Google Scholar
• Leissinger M, Kulkarni R, Zemans RL, et al. Investigating the role of nucleotide-binding oligomerization domain–like receptors in bacterial lung infection. Am J Respir Crit Care Med. 2014;189:1461–1468. doi: 10.1164/rccm.201311-2103PP
   PubMed Web of Science ®Google Scholar
• Pragman AA, Berger JP, Williams BJ. Understanding persistent bacterial lung infections. Clin Pulm Med. 2016;23:57–66. doi: 10.1097/CPM.0000000000000108
   PubMedGoogle Scholar
• Hoe S, Semler DD, Goudie AD, et al. Respirable bacteriophages for the treatment of bacterial lung infections. J Aerosol Med Pulm Drug Deliv. 2013;26:317–335. doi: 10.1089/jamp.2012.1001
   PubMed Web of Science ®Google Scholar
• Lee SH, Bajracharya R, Min JY, et al. Strategic approaches for colon targeted drug delivery: an overview of recent advancements. Pharmaceutics. 2020;12:68. doi: 10.3390/pharmaceutics12010068
   PubMed Web of Science ®Google Scholar
• Cohen TS, Hilliard JJ, Jones-Nelson O, et al. Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections. Sci Transl Med. 2016;8: doi: 10.1126/scitranslmed.aad9922
   Web of Science ®Google Scholar
• Cipolla D, Blanchard J, Gonda I. Development of liposomal ciprofloxacin to treat lung infections. Pharmaceutics. 2016;8:6. doi: 10.3390/pharmaceutics8010006
   PubMed Web of Science ®Google Scholar
• Entezari M, Ghanbarirad M, Taheriazam A, et al. Long non-coding RNAs and exosomal lncRnas: potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling. Biomed Pharmacother. 2022;150:112963. doi: 10.1016/j.biopha.2022.112963
   PubMed Web of Science ®Google Scholar
• Lee W-H, Loo C-Y, Ghadiri M, et al. The potential to treat lung cancer via inhalation of repurposed drugs. Adv Drug Deliv Rev. 2018;133:107–130. doi: 10.1016/j.addr.2018.08.012
   PubMed Web of Science ®Google Scholar
• Wang Z, Kim J, Zhang P, et al. Current therapy and development of therapeutic agents for lung cancer. Cell Insight. 2022;1:100015. doi: 10.1016/j.cellin.2022.100015
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. doi: 10.3322/caac.21332
   PubMed Web of Science ®Google Scholar
• Baghdan E, Duse L, Schüer JJ, et al. Development of inhalable curcumin loaded nano-in-microparticles for bronchoscopic photodynamic therapy. Eur J Pharmaceut Sci. 2019;132:63–71. doi: 10.1016/j.ejps.2019.02.025
   PubMed Web of Science ®Google Scholar
• Liu Q, Guan J, Qin L, et al. Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery. Drug Discov Today. 2020;25:150–159. doi: 10.1016/j.drudis.2019.09.023
   PubMed Web of Science ®Google Scholar
• Jain H, Bairagi A, Srivastava S, et al. Recent advances in the development of microparticles for pulmonary administration. Drug Discov Today. 2020;25:1865–1872. doi: 10.1016/j.drudis.2020.07.018
   PubMed Web of Science ®Google Scholar
• Hu D, Pan Y, Chen G. Colorectal cancer liver metastases: an update of treatment strategy and future perspectives, surgery in practice and science. 2021;7:100042. doi: 10.1016/j.sipas.2021.100042
   Google Scholar
• Matos AI, Carreira B, Peres C, et al. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. JControlled Release. 2019;307:108–138. doi: 10.1016/j.jconrel.2019.06.017
   PubMed Web of Science ®Google Scholar
• Kawczyk-Krupka A, Bugaj AM, Latos W, et al. Photodynamic therapy in colorectal cancer treatment: the state of the art in clinical trials. Photodiagnosis Photodyn Ther. 2015;12:545–553. doi: 10.1016/j.pdpdt.2015.04.004
   PubMed Web of Science ®Google Scholar
• Huang CQ, Min Y, Wang SY, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence. Oncotarget. 2017;8:55657–55683. doi: 10.18632/oncotarget.17497
   PubMedGoogle Scholar
• Hani U, Honnavalli YK, Begum MY, et al. Colorectal cancer: a comprehensive review based on the novel drug delivery systems approach and its management. J Drug Deliv Sci Technol. 2021;63:102532. doi: 10.1016/j.jddst.2021.102532
   Web of Science ®Google Scholar
• dos Santos AM, Carvalho SG, Ferreira LMB, et al. Understanding the role of electrostatic interactions on the association of 5-fluorouracil to chitosan-TPP nanoparticles, Colloids Surf a Physicochem Eng Asp. Colloids Surf A Physicochem Eng Asp. 2022;640:640. doi: 10.1016/j.colsurfa.2022.128417
   Web of Science ®Google Scholar
• Saeid Seyedian S, Nokhostin F, Dargahi Malamir M. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. JMedLife. 2019;12(2):113–122. doi: https://doi.org/10.25122/jml-2018-0075
   Google Scholar
• Kotla NG, Rana S, Sivaraman G, et al. Bioresponsive drug delivery systems in intestinal inflammation: state-of-the-art and future perspectives. Adv Drug Deliv Rev. 2019;146:248–266. doi: 10.1016/j.addr.2018.06.021
   PubMed Web of Science ®Google Scholar
• Danese S, Vuitton L, Peyrin-Biroulet L. Biologic agents for IBD: practical insights. Nat Rev Gastroenterol Hepatol. 2015;12:537–545. doi: 10.1038/nrgastro.2015.135
   PubMed Web of Science ®Google Scholar
• Fakhoury M, Al-Salami H, Negrulj R, et al. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res. 2014;113. doi: 10.2147/JIR.S65979
   PubMedGoogle Scholar
• Teruel AH, Gonzalez-Alvarez I, Bermejo M, et al. New insights of oral colonic drug delivery systems for inflammatory bowel disease therapy. Int J Mol Sci. 2020;21:6502. doi: 10.3390/ijms21186502
   PubMed Web of Science ®Google Scholar
• Meneguin AB, Silvestre ALP, Sposito L, et al. The role of polysaccharides from natural resources to design oral insulin micro- and nanoparticles intended for the treatment of diabetes mellitus: a review. Carbohydr Polym. 2021;256:117504. doi: 10.1016/j.carbpol.2020.117504
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang C, Li K, et al. Recent advances of nanomedicine-based strategies in diabetes and complications management: diagnostics, monitoring, and therapeutics. J Controlled Release. 2021;330:618–640. doi: 10.1016/j.jconrel.2021.01.002
   PubMed Web of Science ®Google Scholar
• Delivery D. Fluorescent aliphatic hyperbranched polyether: chromophores-free and without any N and P atoms. Phys Chem Chem Phys. 2016. doi: 10.1039/x0xx00000x
   Web of Science ®Google Scholar
• Chen M-C, Sonaje K, Chen K-J, et al. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials. 2011;32:9826–9838. doi: 10.1016/j.biomaterials.2011.08.087
   PubMed Web of Science ®Google Scholar
• Katta M, Mathew BA, Chaturvedi P, et al. Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer’s disease, and parkinson’s disease. Neurol Sci. 2023;44:19–36. doi: 10.1007/s10072-022-06356-6
   PubMed Web of Science ®Google Scholar
• Agrawal M, Saraf S, Saraf S, et al. Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Controlled Release. 2018;281:139–177. doi: 10.1016/j.jconrel.2018.05.011
   PubMed Web of Science ®Google Scholar
• Wang Z, Xiong G, Tsang WC, et al. Nose-to-brain delivery. J Pharmacol Exp Ther. 2019;370:593–601. doi: 10.1124/jpet.119.258152
   PubMed Web of Science ®Google Scholar
• André EM, Passirani C, Seijo B, et al. Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: application to Huntington’s disease. Biomaterials. 2016;83:347–362. doi: 10.1016/j.biomaterials.2015.12.008
   PubMed Web of Science ®Google Scholar
• Dimiou S, Lopes RM, Kubajewska I, et al. Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure. Int J Pharm. 2022;618. doi: 10.1016/j.ijpharm.2022.121658
   PubMedGoogle Scholar
• Loira-Pastoriza C, Todoroff J, Vanbever R. Delivery strategies for sustained drug release in the lungs. Adv Drug Deliv Rev. 2014;75:81–91. doi: 10.1016/j.addr.2014.05.017
   PubMed Web of Science ®Google Scholar
• He S, Gui J, Xiong K, et al. A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases. J Nanobiotechnology. 2022;20:1–22. doi: 10.1186/s12951-022-01307-x
   PubMed Web of Science ®Google Scholar
• Naeem M, Awan UA, Subhan F, et al. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Arch Pharm Res. 2020;43:153–169. doi: 10.1007/s12272-020-01219-0
   PubMed Web of Science ®Google Scholar
• Imperiale JC, Nejamkin P, Del Sole MJ, et al. Novel protease inhibitor-loaded nanoparticle-in-microparticle delivery system leads to a dramatic improvement of the oral pharmacokinetics in dogs. Biomaterials. 2014;37:1–12. doi: 10.1016/j.biomaterials.2014.10.026
   PubMed Web of Science ®Google Scholar
• Arévalo-Pérez R, Maderuelo C, Lanao JM. Recent advances in colon drug delivery systems. J Controlled Release. 2020;327:703–724. doi: 10.1016/j.jconrel.2020.09.026
   PubMed Web of Science ®Google Scholar
• Zeeshan M, Ali H, Khan S, et al. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. Int J Pharm. 2019;558:201–214. doi: 10.1016/j.ijpharm.2018.12.074
   PubMed Web of Science ®Google Scholar
• Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS Pharm Sci Tech. 2015;16:731–741. doi: 10.1208/s12249-015-0350-9
   PubMed Web of Science ®Google Scholar
• Hua S, Marks E, Schneider JJ, et al. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine. 2015;11:1117–1132. doi: 10.1016/j.nano.2015.02.018
   PubMed Web of Science ®Google Scholar
• Carvalho FC, Bruschi ML, Evangelista RC, et al. Mucoadhesive drug delivery systems. Braz J Pharm Sci. 2010;46:1–17. doi: 10.1590/S1984-82502010000100002
   Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64:557–570. doi: 10.1016/j.addr.2011.12.009
   PubMed Web of Science ®Google Scholar
• Carvalho FC, Calixto G, Hatakeyama IN, et al. Rheological, mechanical, and bioadhesive behavior of hydrogels to optimize skin delivery systems. Drug Dev Ind Pharm. 2013;39:1750–1757. doi: 10.3109/03639045.2012.734510
   PubMed Web of Science ®Google Scholar
• Wang D, Wu Q, Guo R, et al. Magnetic liquid metal loaded nano-in-micro spheres as fully flexible theranostic agents for SMART embolization. Nanoscale. 2021;13:8817–8836. doi: 10.1039/d1nr01268a
   PubMed Web of Science ®Google Scholar
• Hatanaka T, Arai H, Kakizaki S. Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Hepatol. 2018;10:485–495. doi: 10.4254/wjh.v10.i7.485
   PubMed Web of Science ®Google Scholar
• Wang K, Yu H-M, Xiang Y-J, et al. Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial. Future Oncol. 2022;18:3367–3375. doi: 10.2217/fon-2022-0188
   PubMed Web of Science ®Google Scholar
• Bi Y, Du T, Pan W, et al. Transcatheter arterial chemoembolization is safe and effective for patients with late-stage or recurrent oral carcinoma. Front Oncol. 2022;12: doi: 10.3389/fonc.2022.831583
   Web of Science ®Google Scholar
• Ruggeri M, Vigani B, Boselli C, et al. Smart nano-in-microparticles to tackle bacterial infections in skin tissue engineering. Mater Today Bio. 2022;16:100418. doi: 10.1016/j.mtbio.2022.100418
   PubMedGoogle Scholar
• Yandrapu SK, Upadhyay AK, Petrash JM, et al. Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab. Mol Pharm. 2013;10:4676–4686. doi: 10.1021/mp400487f
   PubMed Web of Science ®Google Scholar
• Wang H, Agarwal P, Xiao Y, et al. A nano-in-micro system for enhanced stem cell therapy of ischemic diseases. ACS Cent Sci. 2017;3:875–885. doi: 10.1021/acscentsci.7b00213
   PubMed Web of Science ®Google Scholar
• Cardoso VMDO, de Brito NAP, Ferreira NN, et al. Design of mucoadhesive gellan gum and chitosan nanoparticles intended for colon-specific delivery of peptide drugs. Colloids Surf A Physicochem Eng Asp. 2021;628:127321. doi: 10.1016/j.colsurfa.2021.127321
   Web of Science ®Google Scholar
• de Oliveira Cardoso VM, Evangelista RC, Daflon Gremião MP, et al. Insights into the impact of cross-linking processes on physicochemical characteristics and mucoadhesive potential of gellan gum/retrograded starch microparticles as a platform for colonic drug release. J Drug Deliv Sci Technol. 2020;55:101445. doi: 10.1016/j.jddst.2019.101445
   Web of Science ®Google Scholar
• Carvalho S, Silveira MJ, Domingues M, et al. Multicellular quadruple colorectal cancer spheroids as an in vitro tool for antiangiogenic potential evaluation of nanoparticles. Adv Ther. 2023;6. doi: 10.1002/adtp.202200282
   Google Scholar